QL
MLYS icon

Quarry LP’s Mineralys Therapeutics MLYS Stock Holding History

Quarry LP’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Buy
12,616
+2,616
+26% +$71.8K 0.03% 225
2026
Q1 		$271K Buy
+10,000
New +$293K 0.05% 263
2025
Q2 		– Sell
-7,000
Closed -$111K – 1935
2025
Q1 		$111K Buy
+7,000
New +$80.5K 0.02% 483

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Quarry LP's MLYS Position: Q2 2026 in Review

Quarry LP increased its Mineralys Therapeutics (MLYS) stake by 26% in Q2 2026, buying an estimated $71.8K and bringing the position to 12,616 shares worth $340K. The position accounts for 0.03% of the portfolio, ranked #225.

Quarry LP first reported a position in MLYS in Q1 2025 and has held it in 3 quarters since. 226 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • Quarry LP held 12,616 shares of Mineralys Therapeutics worth $340K as of Q2 2026.
  • Quarry LP bought 2,616 Mineralys Therapeutics shares in Q2 2026, an estimated $71.8K.
  • Mineralys Therapeutics made up 0.03% of Quarry LP's portfolio in Q2 2026, its #225 holding.
  • Quarry LP first reported a position in Mineralys Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 226 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.